These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 27565926)

  • 1. Severe agranulocytosis in a patient with metastatic non-small-cell lung cancer treated with nivolumab.
    Tabchi S; Weng X; Blais N
    Lung Cancer; 2016 Sep; 99():123-6. PubMed ID: 27565926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature.
    Ruiz-Bañobre J; Pérez-Pampín E; García-González J; Gómez-Caamaño A; Barón-Duarte FJ; López-López R; Vázquez-Rivera F
    Lung Cancer; 2017 Jun; 108():217-221. PubMed ID: 28625638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot trial of nivolumab treatment for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia.
    Fujimoto D; Morimoto T; Ito J; Sato Y; Ito M; Teraoka S; Otsuka K; Nagata K; Nakagawa A; Tomii K
    Lung Cancer; 2017 Sep; 111():1-5. PubMed ID: 28838377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition.
    Naqash AR; Appah E; Yang LV; Muzaffar M; Marie MA; Mccallen JD; Macherla S; Liles D; Walker PR
    J Immunother Cancer; 2019 Jul; 7(1):169. PubMed ID: 31277704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Factors of Nivolumab-induced Hypothyroidism in Patients with Non-small Cell Lung Cancer.
    Maekura T; Naito M; Tahara M; Ikegami N; Kimura Y; Sonobe S; Kobayashi T; Tsuji T; Minomo S; Tamiya A; Atagi S
    In Vivo; 2017; 31(5):1035-1039. PubMed ID: 28882978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coincidence of immunotherapy-associated hemophagocytic syndrome and rapid tumor regression.
    Takeshita M; Anai S; Mishima S; Inoue K
    Ann Oncol; 2017 Jan; 28(1):186-189. PubMed ID: 28043982
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report.
    Li H; Ma W; Yoneda KY; Moore EH; Zhang Y; Pu LL; Frampton GM; Molmen M; Stephens PJ; Li T
    J Hematol Oncol; 2017 Feb; 10(1):64. PubMed ID: 28245875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic leptomeningeal metastasis improvement with nivolumab in advanced non-small cell lung cancer patient.
    Gion M; Remon J; Caramella C; Soria JC; Besse B
    Lung Cancer; 2017 Jun; 108():72-74. PubMed ID: 28625652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and relapse of interstitial lung disease in nivolumab-treated patients with non-small cell lung cancer.
    Sata M; Sasaki S; Oikado K; Saito Y; Tominaga J; Sakai F; Kato T; Iwasawa T; Kenmotsu H; Kusumoto M; Baba T; Endo M; Fujiwara Y; Sugiura H; Yanagawa N; Ito Y; Sakamoto T; Ohe Y; Kuwano K
    Cancer Sci; 2021 Apr; 112(4):1506-1513. PubMed ID: 33125784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous Pemphigoid Associated With a New Combination Checkpoint Inhibitor Immunotherapy.
    Fontecilla NM; Khanna T; Bayan CY; Antonov NA; Geskin LJ
    J Drugs Dermatol; 2019 Jan; 18(1):103-104. PubMed ID: 30681807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case Report of Steroid Responsive Nivolumab-Induced Encephalitis.
    Richard K; Weslow J; Porcella SL; Nanjappa S
    Cancer Control; 2017; 24(5):1073274817729069. PubMed ID: 28975824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nivolumab-induced organizing pneumonitis in a patient with lung sarcomatoid carcinoma.
    Gounant V; Brosseau S; Naltet C; Opsomer MA; Antoine M; Danel C; Khalil A; Cadranel J; Zalcman G
    Lung Cancer; 2016 Sep; 99():162-5. PubMed ID: 27565934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-related pancreatitis secondary to nivolumab in a patient with recurrent lung adenocarcinoma: A case report.
    Ikeuchi K; Okuma Y; Tabata T
    Lung Cancer; 2016 Sep; 99():148-50. PubMed ID: 27565931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced myocarditis after nivolumab treatment in a patient with PDL1- negative squamous cell carcinoma of the lung.
    Semper H; Muehlberg F; Schulz-Menger J; Allewelt M; Grohé C
    Lung Cancer; 2016 Sep; 99():117-9. PubMed ID: 27565924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic joint involvement or inflammatory arthritis? A conundrum with immune checkpoint inhibitor-related adverse events.
    Albayda J; Bingham CO; Shah AA; Kelly RJ; Cappelli L
    Rheumatology (Oxford); 2018 Apr; 57(4):760-762. PubMed ID: 29342300
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune Thrombocytopenia Induced by Nivolumab in a Metastatic Non-Small Cell Lung Cancer Patient.
    Karakas Y; Yuce D; Kılıckap S
    Oncol Res Treat; 2017; 40(10):621-622. PubMed ID: 28950270
    [No Abstract]   [Full Text] [Related]  

  • 17. Diffuse pseudoprogression in a patient with metastatic non-small-cell lung cancer treated with Nivolumab.
    Curioni-Fontecedro A; Ickenberg C; Franzen D; Rogler G; Burger IA; van den Broek M
    Ann Oncol; 2017 Aug; 28(8):2040-2041. PubMed ID: 28838208
    [No Abstract]   [Full Text] [Related]  

  • 18. Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancer.
    Galli G; Proto C; Cossa M; Valeri B; Sdao S; Signorelli D; Imbimbo M; de Braud F; Garassino MC; Lo Russo G
    Tumori; 2019 Dec; 105(6):NP57-NP62. PubMed ID: 31456503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atezolizumab in advanced non-small-cell lung cancer.
    Brower V
    Lancet Oncol; 2017 Aug; 18(8):e434. PubMed ID: 28648559
    [No Abstract]   [Full Text] [Related]  

  • 20. The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer.
    Tanvetyanon T; Creelan BC; Antonia SJ
    Expert Rev Anticancer Ther; 2016 Sep; 16(9):903-10. PubMed ID: 27488231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.